The Journal of Infectious Diseases · 2014 · 37 citations · 32 references
Veterinary MedicineInfectious DiseasesPharmacologyAntimicrobial PharmacologyImmunotherapySepsisAntibacterial PharmacologyAntibody-mediated ProtectionBacterial ToxinsHumoral ImmunityTherapeutic Monoclonal AntibodiesToxin-mediated PathogenesisAntibodiesAntibody-mediated Bacterial ProtectionAntibody-mediated Immunity To BacteriaAntibody-mediated Toxin NeutralizationMonoclonal Antibody TherapeuticsStaphylococcal EnterotoxinsSuperantigen RecognitionTherapeutic Toxin Applications
BACKGROUND: Staphylococcal enterotoxin B (SEB), a potential biological warfare agent, is a potent superantigen that contributes to the virulence of methicillin-resistant Staphylococcus aureus (MRSA), which is a major health threat in the United States. Efforts to develop toxin-neutralizing antibodies as adjunctive therapies are justified, given the high mortality and frequent failure of therapy despite available antibiotics. METHODS: Murine SEB-specific mAb 20B1 was humanized, and treatment benefits of Hu-1.6/1.1 and Hu-1.4/1.1 variants were investigated in mice in an SEB intoxication model, as well as in sepsis and deep-tissue infection models. RESULTS: Hu-1.6/1.1 and Hu-1.4/1.1 protected mice against SEB-induced lethal shock. Hu-1.6/1.1 also enhanced survival of mice that developed fatal sepsis after challenge with a SEB-producing MRSA strain. Combined treatment of Hu-1.6/1.1 with vancomycin further increased survival and altered cytokine responses, compared with monotherapy with either monoclonal antibody or vancomycin alone. Efficacy was also demonstrated in the deep-tissue infection model, where Hu-1.4/1.1 bound to SEB in vivo and decreased abscess formation, as well as proinflammatory cytokine levels. CONCLUSIONS: SEB-neutralizing mAb 20B1 was successfully humanized. The mAb affects outcome by modulating the proinflammatory host response in both the sepsis and the intoxication models, which justifies further development.
32
IMGT(R), the international ImMunoGeneTics information system(R)
Marie‐Paule Lefranc, Véronique Giudicelli, Chantal Ginestoux et al. · Nucleic Acids Research · 2008 · 1.1K citations · Full text
Life Sciences, Genetics, Immunology +14
Human Botulism Immune Globulin for the Treatment of Infant Botulism
Stephen S. Arnon, Robert Schechter, Susan E. Maslanka et al. · New England Journal of Medicine · 2006 · 499 citations · Full text
Raxibacumab for the Treatment of Inhalational Anthrax
Thi-Sau Migone, G. Mani Subramanian, John Zhong et al. · New England Journal of Medicine · 2009 · 289 citations · Full text